Amarin's Vascepa May Face Generic Competition In US Next Year After Patents Ruled Invalid

 
• By Brenda Sandburg
  
Fish oil
Court rules patents on Amarin's fish oil pill Vascepa are invalid
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet